Caricamento...

Phase II trial of neoadjuvant chemotherapy with docetaxel, nedaplatin, and S1 for advanced esophageal squamous cell carcinoma

Although standard chemotherapy for esophageal cancer patients is fluorouracil and cisplatin, the prognosis is still unsatisfactory. A new therapeutic regimen combining docetaxel, cisplatin, and 5‐fluorouracil was recently developed to improve both local and distant tumor control. We developed a new...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Cancer Sci
Autori principali: Tanaka, Yoshihiro, Yoshida, Kazuhiro, Tanahashi, Toshiyuki, Okumura, Naoki, Matsuhashi, Nobuhisa, Yamaguchi, Kazuya
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2016
Soggetti:
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC4968606/
https://ncbi.nlm.nih.gov/pubmed/27061001
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cas.12943
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !